Kent, United Kingdom

Dennis Douroumis

USPTO Granted Patents = 2 


 

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2022-2024

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations of Dennis Douroumis

Introduction

Dennis Douroumis is a notable inventor based in Kent, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative methods for producing tablet compositions. With a total of two patents to his name, Douroumis has demonstrated a commitment to advancing pharmaceutical technology.

Latest Patents

Douroumis's latest patents include a method of producing an extruded composition and a method of producing a granulated composition. The first patent relates to a method for creating a direct compression tablet composition that involves processing ibuprofen, a hydrophilic polymer, and an inorganic excipient through an extrusion process. This innovation is particularly beneficial for preparing oral dissolvable tablets. The second patent focuses on producing an extruded, powdered/granulated composition that incorporates an active pharmaceutical ingredient (API) absorbed within the pores of a porous inorganic excipient. This method enhances the delivery and effectiveness of the API.

Career Highlights

Throughout his career, Douroumis has worked with several companies, including Cubic Pharmaceuticals Ltd. and Delta Pharmaceuticals Ltd. His experience in these organizations has allowed him to refine his skills and contribute to the development of pharmaceutical innovations.

Collaborations

Douroumis has collaborated with notable professionals in the field, including Mohammed Maniruzzaman and Saumil Kiritkumar Bhatt. These collaborations have further enriched his work and expanded the impact of his inventions.

Conclusion

Dennis Douroumis is a distinguished inventor whose work in pharmaceutical innovations has led to the development of valuable methods for producing effective tablet compositions. His contributions continue to influence the industry and improve patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…